Glenmark Life Sciences Ltd. IPO open in the market for Subscription as on 27th July 2021 and closes on 29th July 2021. The company plan to raise Rs. 1513.60 crores from market via initial public offer with price band of Rs. 695 to 720 per equity share.
About Glenmark Life Sciences Ltd.
Glenmark Life Sciences Ltd.is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs).
Company are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, Company have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally.
With 120 APIs in our portfolio, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality.
Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 540 pharma companies in multiple countries.
We are a research and development (R&D)-driven API manufacturer, focused on undertaking dedicated R&D in our existing products and in areas where we believe there is growth potential in the future. We believe that maintaining high standards of process innovation and quality in our R&D and manufacturing operations is critical to our brand and to developing long-term relationships with our customers.
We have steadily built scale in our product offerings and reach, leveraging state-of-the-art laboratories and manufacturing locations. GLS partners with 16 of the top 20 generic companies in the world (source: A Year of Surprises Shakes Up Off-Patent Industry" | Informa, 2020) and serves customers in multiple regions, including North America, Europe, Japan, Latin America, India and ROW.
We place strong emphasis on customer experience, and our local presence in markets like North America, United Kingdom and Latin America helps us understand customers' requirements.
Company Promoters:
Glenmark Pharmaceuticals Limited is the promoter of the company.
Glenmark Life Sciences Ltd IPO Date & Price Band, Market Lot, Allotment & Listing details:
|
IPO Open |
27th July 2021 |
|
IPO Close |
29th July 2021 |
|
IPO Size |
Rs.1513.60 Crores |
|
Fresh Issue |
Rs.1060 Crores |
|
Offer for Sale |
Rs.453.60 Crores, 63 lacs Share |
|
Face Value |
Rs.2 Per Equity Share |
|
Price Band |
Rs.695 to Rs.720 Per Share |
|
Listing on |
BSE & NSE |
|
Retail Quota & Lots |
35% - 3,67,888 Lots |
|
Employee Disc |
Rs. - per share |
|
Total Share Issue |
2,10,22,222 Shares |
|
Minimum Lot Size |
Mini. 20 Shares - 1 Lots |
|
Minimum Amount |
Rs. 14,400/- |
|
Maximum Lot Size |
Maxi. – 260 Shares – 13 Lots |
|
Maximum Amount |
Rs.1,87,200/- |
|
Basis of Allotment |
3rd August 2021 |
|
Refunds |
4th August 2021 |
|
Credit to Demat A/c |
5th August 2021 |
|
Listing Date |
6th August 2021 |
Company Audited Financials Summery:
Summary of financial Information (Restated Consolidated)
|
Rs. in Crores |
||||
|
|
FY2018 |
FY2019 |
FY2020 |
FY2021 |
|
Revenue |
1202.2 |
1405.5 |
1549.3 |
1886.0 |
|
Expenses |
892.8 |
1001.7 |
1128.2 |
1415.0 |
|
Net income |
229.5 |
293.5 |
313.6 |
351.1 |
|
NI Ratio (%) |
19.1% |
20.9% |
20.2% |
18.6% |
|
EPS |
- |
24.64 |
29.04 |
32.61 |
Objectives of the IPO:
The Net proceeds of IPO will be utilized for the following purposes;
- To make payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company.
- To finance capital expenditure requirements.
- To meet general corporate purposes.
Company Contact Information
Glenmark Life Sciences LimitedPlot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213,
Phone: +91 2189 234456/ +91 2189
Email: complianceofficer@glenmarklifesciences.com
Website: http://www.glenmarklifesciences.com/
IPO Registrar
KFintech Private LimitedKFintech, Tower-B, Plot No 31 & 32,
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India - 500 032.
Phone: 04067162222, 04079611000
Email: glenmark.ipo@kfintech.com
Website: https://karisma.kfintech.com/
FAQs on Glenmark Life Sciences IPO
When Glenmark Life Sciences IPO will open for retail Investors?The IPO is to open for subscription on 27th July 2021 for all type Investors.
What is Glenmark Life Sciences IPO Investors Quota?
The investors' Quota for QIB 50%, NII 15%, and Retail 35%.
What is Glenmark Life Sciences IPO Size for retail?
Glenmark Life Sciences IPO size is Rs.1513.60 crores and for retail is Rs.530 crores.
What is Glenmark Life Sciences IPO offer Price ?
Glenmark Life Sciences IPO offer Price is Rs.695 to Rs.720.
What is Glenmark Life Sciences IPO Minimum Lot Size?
The minimum order quantity is 20 Shares with Rs.14,400.
What is Glenmark Life Sciences IPO Allotment Date?
Glenmark Life Sciences IPO allotment date is 3rd August 2021.
Glenmark Life Sciences IPO listing on NSE & BSE as on 6th August 2021.
How to Apply IPO Application?
You can fill and submit your IPO application online at your convenience anytime before an issue closes. This can be done through the your Broker app or website.
You can apply IPO by following ways :
- You can apply any IPO via netbanking of your bank account login in that you will ASBA online service available and in that menu you will see the IPO name in which you want to apply, click in apply button. Enter the your demate A/c details, Quantity and price. click on submit IPO Application.
- You can also apply ASBA online by UPI through your stock brokers/ mobile application. For that You will need a mobile phone with a SIM linked to your bank account offering the UPI facility and a debit card to create your UPI ID.
- You can also apply through your stock brokers by filling up the physical/offline form.
How to check IPO Allotment Status ?
1. Go to on IPO allotment link - https://kcas.kfintech.com/ipostatus/
2. Select IPO Name from drop down menu bar from list of IPO
3. Select any one Option from PAN Number, Application Number or DP ID Option
4. As per selection Enter PAN Number, Application Number or DP ID Option
5. Click on 'Search' Button
6. You will get your IPO Allotment on the screen (Phone / Computer).
No comments:
Post a Comment